What is the significance of an elevated Albumin (Albumin)/Creatinine (Creatinine) ratio in a random urine sample, indicating microalbuminuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The albumin/creatinine ratio (ACR) of 33 mg/g in a random urine sample indicates microalbuminuria, which is an early sign of kidney damage and requires prompt follow-up and management. This result falls in the moderately increased albuminuria range (30-300 mg/g) and is associated with an increased risk of renal and cardiovascular outcomes 1.

Key Considerations

  • The patient should undergo confirmation of this result with at least one additional urine sample, as variability can occur 1.
  • If confirmed, lifestyle modifications should be implemented immediately, including:
    • Blood pressure control (target <130/80 mmHg)
    • Diabetes management if applicable (target HbA1c <7%)
    • Dietary sodium restriction (<2.3g/day)
    • Regular exercise
  • Medication therapy with an ACE inhibitor (like lisinopril 10-40 mg daily) or an ARB (such as losartan 50-100 mg daily) should be considered, especially if the patient has hypertension or diabetes 1.

Monitoring and Follow-up

  • Regular monitoring of kidney function with eGFR and repeat ACR measurements every 3-6 months is essential to assess response to therapy and progression of disease 1.
  • The patient should be referred to a physician experienced in the care of kidney disease if there is uncertainty about the etiology of kidney disease, difficult management issues, or rapidly progressing kidney disease 1.

Conclusion Not Applicable - Outcome Based Answer Only

This level of albuminuria indicates that kidney damage is occurring, likely due to increased glomerular pressure or inflammation, and early intervention can significantly slow progression to more severe kidney disease and reduce cardiovascular risk 1.

From the Research

Albumin/Creatinine Ratio

  • The albumin/creatinine ratio (ACR) is a test used to detect kidney damage and is also a risk factor for cardiovascular disease and mortality 2, 3.
  • A random urinary ACR based on a random urine sample correlates well with 24-hour urinary albumin excretion measurement 2.
  • The ACR can be used as a screening test for microalbuminuria, but it has limitations, particularly in older adults, where the false-positive rate increases with age 4.

Interpretation of ACR Results

  • An ACR of 30 mg/g or greater is considered abnormal and may indicate kidney damage 5, 4.
  • The ACR can be influenced by various factors, including age, sex, and blood pressure 4.
  • Point-of-care testing devices, such as the CLINITEK Microalbumin and DCA 2000+, can be used to measure ACR and rule out increased urinary albumin excretion 2.

Clinical Significance

  • The ACR is an important marker for kidney disease and cardiovascular risk 3, 6.
  • Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) can decrease albuminuria and slow the progression of kidney disease 6.
  • The use of ACEIs and ARBs has increased over time, particularly in patients with chronic kidney disease (CKD) 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of measures of urinary albumin excretion.

American journal of epidemiology, 2006

Research

Albumin to creatinine ratio: a screening test with limitations.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002

Research

Effects of ACE Inhibitors and Angiotensin Receptor Blockers in Normotensive Patients with Diabetic Kidney Disease.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.